7 Results for "

anti-arrhythmia

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "anti-arrhythmia" in MCE Product Catalog:

22
22 Cited Publications
Cat. No.: HY-N0485
CAS No.: 5088-90-4
Liensinine Diperchlor​ate is a major isoquinoline alkaloid, extracted from the seed embryo of Nelumbo nucifera Gaertn. Liensinine Diperchlor​ate inhibits late-stage autophagy/mitophagy through blocking autophagosome-lysosome fusion. Liensinine Diperchlor​ate has a wide range of biological activities, including anti-arrhythmias, anti-hypertension, anti-pulmonary fibrosis, relaxation on vascular smooth muscle, etc .
loading...
    loading...
Cat. No.: HY-W492795
CAS No.: 10447-38-8
Target:  

Histamine Receptor

Research Areas:  

Cardiovascular Disease

Quifenadine hydrochloride is an H1-histamine receptor blocker and can be used in the research of anti-arrhythmia .
loading...
    loading...
Cat. No.: HY-N8228
CAS No.: 2306139-04-6
17-Hydroxyneomatrine, extracted from Sophora flavescens, can well inhibit the growth of human cervical carcinoma Hela cells, has the wide-range antibacterial, anti-allergy, anti-tumor, anti-arrhythmia, swelling-subsiding diuresis, immunizing, and biological regulation functions .
loading...
    loading...
Cat. No.: HY-137986
CAS No.: 1821638-43-0
Purity:  98.9%
Target:  

Potassium Channel

Research Areas:  

Inflammation/Immunology

LUF7244 is a selective allosteric modulator of Kv11.1 channels. LUF7244 inhibits early afterdepolarizations. LUF7244 can be used for anti-arrhythmia research .
loading...
    loading...
Cat. No.: HY-144802
CAS No.: 1186049-49-9
Target:  

Potassium Channel

Research Areas:  

Cardiovascular Disease

DDO-02001 is a moderately potent Kv1.5 potassium channel inhibitor with an IC50 value of 17.7 μM. DDO-02001 can be used for researching anti-arrhythmia .
loading...
    loading...
Cat. No.: HY-119850A
CAS No.: 1233219-11-8
Synonyms: ARM036 sodium; S44121 sodium
Target:  

Calcium Channel

Research Areas:  

Cardiovascular Disease

Aladorian (ARM036; S44121) sodium is a non-peptidic ryanodine receptor 2 (RyR2) stabilizer. Aladorian sodium stabilizes RyR2 channels and rectifies abnormal Ca²⁺ handling in cardiomyocytes. Aladorian sodium improves cardiomyocyte Ca 2+ homeostasis independent of dystrophin restoration. Aladorian sodium attenuates early cardiomyopathy and enhances left ventricular function in a canine muscular dystrophy model. Aladorian sodium can be used for the research of heart failure, Duchenne muscular dystrophy-associated cardiomyopathy and muscular dystrophy .
loading...
    loading...
Cat. No.: HY-184751
CAS No.: 58409-59-9
Research Areas:  

Cardiovascular Disease

Bucumolol is an orally active β-adrenergic receptor blocker. Bucumolol inhibits Renin release. Bucumolol exhibits activities including local anesthesia, antiarrhythmia, antihypertension, heart rate reduction, negative inotropy, cardiac action potential inhibition, and action potential duration shortening. Bucumolol does not increase cardiac electrical threshold, prolong atrial refractory period, or affect body weight in rodents. Bucumolol can be used in research related to arrhythmia and hypertension .
loading...
    loading...